Alvotech says FDA closes Reykjavik plant inspection with VAI classification - ALVO News | RalliesAlvotech says FDA closes Reykjavik plant inspection with VAI classification
A
ALVO• FDA closes Reykjavik site inspection with VAI classification
- FDA closed its May 2026 inspection of Alvotech’s Reykjavik manufacturing site with a Voluntary Action Indicated (VAI) classification.
- The outcome reduces regulatory overhang on the plant’s compliance status as Alvotech works to move recent biosimilar BLA filings toward approval.
•
